After an introduction covering the basics Dr Kennedy goes on to cover some of the advanced research topics covered at the International Workshop on CLL May 2017 under the headings: TP53 gene, other significant genes and clonal evolution, IGHV sub clonal architecture and Novel therapeutic approaches.
Who we are
We are a patient led UK charity, our mission is to support and empower CLL patients, their families and their carers.
Read moreOur 24 hour membership telephone number is: 0800 977 4396
About CLL
CLL is a malignancy of B lymphocytes, one of several types of cells of the immune system.
Read moreAbout CLL
Donate
Donate to support our CLL community
Donate nowHealthUnlocked
Connect to others who understand
Open in a new tab
